TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TLRY

Tilray Inc

Healthcare · Drug Manufacturers - Specialty & Generic

4.00$ +1.3% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Income Statement

Tilray Inc (TLRY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 282 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement TLRY
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 LTM
240 262 256 313 270 295 268 308 288 304 282 282 1,156
180 198 189 201 189 209 193 215 209 224 207 197 837
60 64 67 112 81 86 75 93 79 80 75 84 319
0.1 0.1 0.1 0.5 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.2 0.4
55 59 54 65 60 65 57 50 57 72 69 61 258
106 121 178 135 130 145 1,173 2,074 76 111 102 89 378
-47 -57 -111 -23 -49 -59 -1,098 -1,981 2.9 -31 -27 -4.5 -60
13 12 12 13 13 11 12 5.4 9.2 7.5 6.8 6.6 30
-66 -67 -146 -59 -46 -116 -1,144 -1,912 -1.1 -56 -32 -24 -113
9.8 -4.6 -3.9 -38 1.2 2.8 1.7 -172 -3.1 5.0 2.7 14 18
-97 -66 -126 -43 -53 -119 -1,140 -1,747 -0.4 -63 -36 -50 -149
-11 -13 -90 15 11 -58 -1,084 -1,844 30 -26 -2.1 15 16

LTM = last twelve months (sum of the four most recent quarters).

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?